Neurones Stock

Neurones FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Neurones (NRO.PA) as of Aug 5, 2026 is 135.07 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 137.80 % — a change of -1.98% (lower).

FCF Conversion

135.07 %

YoY

-1.98%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Neurones is 2026 135.07 % . FCF Conversion Rate (FCF/EBITDA) of Neurones was 2025 137.80 % . It decreases by -1.98% lower compared to the previous year.
Access this data via the Eulerpool API

Neurones Stock analysis

What does Neurones do? Neurones SA is a French company specializing in IT services and consulting. It was founded in 1989 and is based in Paris. With over 10,000 employees worldwide, the company operates in over 20 countries and serves clients in various industries such as healthcare, finance, telecommunications, and the public sector. Neurones SA's business model is based on developing and implementing IT projects and providing consulting and support services tailored to its clients' specific needs. The company's divisions include management consulting, system integration, maintenance, and technology services. Its product portfolio includes solutions in CRM, ERP, CMS, as well as cloud computing, cybersecurity, and data analytics. Neurones SA's key products are the Neurones AI Suite, which utilizes AI and machine learning to automate business processes and improve decision-making, and the Smart Health Platform, a cloud-based platform for the healthcare industry. The company's clients include Air France, L'Oréal, PSA Peugeot Citroën, and Orange. Neurones SA emphasizes customer loyalty, with over 80% of its clients being long-term customers. Overall, Neurones SA is a leading IT company that specializes in providing tailored IT solutions and consulting services, and it is well-positioned for future success with its global presence and diverse range of products and services. Neurones is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neurones stock

FCF Conversion Rate (FCF/EBITDA) of Neurones is 135.07 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Neurones changed from 137.80 % to 135.07 %, representing a -1.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Neurones since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Neurones with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Neurones

All Key Metrics — Neurones